BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9011933)

  • 1. [Sex differences in disease course: analysis of the Swiss HIV cohort study].
    Schmid M; Twisselmann W; Jacquat BJ; Ledergerber B; Battegay M; Egger M
    Schweiz Med Wochenschr; 1996 Dec; 126(51-52):2234-6. PubMed ID: 9011933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.
    Battegay M; Wirz M; Steuerwald MH; Egger M
    J Intern Med; 1998 Dec; 244(6):479-87. PubMed ID: 9893101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.
    Sudre P; Rickenbach M; Taffé P; Janin P; Volkart AC; Francioli P;
    Schweiz Med Wochenschr; 2000 Oct; 130(41):1493-500. PubMed ID: 11075414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).
    Stoehr A; Arasteh K; Staszewski S; Brockmeyer N; Albrecht H; Mertenskötter T; Jablonowski H; Emminger C; Rockstroh JK; Baumgarten R; Bogner J; Loch T; Plettenberg A
    Eur J Med Res; 1999 Apr; 4(4):131-4. PubMed ID: 10205287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
    Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
    An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
    Eigenmann C; Flepp M; Bernasconi E; Schiffer V; Telenti A; Bucher H; Wagels T; Egger M; Furrer H;
    Clin Infect Dis; 2003 Apr; 36(7):917-21. PubMed ID: 12652393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)].
    Semela D; Glatz M; Hunziker D; Schmid U; Vernazza PL
    Schweiz Med Wochenschr; 2000 Nov; 130(45):1726-33. PubMed ID: 11109604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pregnancy on maternal AIDS.
    Kumar RM; Uduman SA; Khurrana AK
    J Reprod Med; 1997 Jul; 42(7):429-34. PubMed ID: 9252934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
    Jubault V; Pacanowski J; Rabian C; Viard JP
    Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics.
    Hirschhorn LR; McInnes K; Landon BE; Wilson IB; Ding L; Marsden PV; Malitz F; Cleary PD
    Womens Health Issues; 2006; 16(3):104-12. PubMed ID: 16765286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 16. Stopping PCP prophylaxis after suppressing HIV.
    Norton M
    GMHC Treat Issues; 1999 Apr; 13(4):4-5. PubMed ID: 11366976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Swiss HIV Cohort Study--a link between clinical research and medical practice].
    Opravil M; Rickenbach M; Ledergerber B
    Ther Umsch; 1998 May; 55(5):329-34. PubMed ID: 9643131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outline of the Human Retrovirus Registry: profile of a Puerto Rican HIV infected population.
    Gómez MA; Velázquez M; Hunter RF
    Bol Asoc Med P R; 1997; 89(7-9):111-6. PubMed ID: 9419928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.